Chennai: Apollo Hospitals registered 17 per cent growth in revenues in the consolidated performance in Q3FY20. According to a press release, it grew to Rs 25,295 million compared to Rs 21,690 million in Q3FY19, aided by Healthcare services growth of 12 per cent YoY and SAP growth of 22 per cent.
HC services grew 12 per cent YoY was led by growth both in the mature hospitals and New Hospitals which grew 9 per cent YoY and 16 per cent respectively. Earnings before interest, tax, depreciation and amortization (EBITDA) was at Rs 3,195 million in Q3FY20 as against Rs 2,679 million in Q3FY19 a YoY growth of 19 per cent. PAT grew by 9 per cent to Rs 948 million in Q3FY20.
Dr Prathap C Reddy, Chairman, Apollo Hospitals said, ‘Our Prohealth programme has been well received across all our centres, profoundly contributing to our objective of enhancing the focus on preventing Non-Communicable Diseases. Even as we widen the suite of preventive healthcare offerings, we are rapidly evolving our capabilities across key specialties such as Oncology, neurosciences, orthopaedics and critical care to meet the healthcare challenges of the Nation. The progress made by Apollo Proton Cancer Center is heartening, as it has elevated the country into a select league that is leveraging innovative technology to address the rapidly growing epidemic of cancer.’